ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,086.37
0.61%
US Tech 100
21,214.46
1.06%
다우존스 지수
44,156.73
0.30%
Bitcoin
102,173.48
-1.41%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Sartorius Ag (0NIQ) 시세

Sartorius Ag

Sartorius Ag (0NIQ)

LSE
138.25
0.00
(0.00%)
마감 23 1월 1:30AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
138.25
매수가
133.50
매도가
143.00
거래량
734
0.00 일간 변동폭 0.00
138.25 52주 범위 138.25
market_cap
4.732B
전일 종가
138.25
개장가
-
최근 거래 시간
16
@
198
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
249
발행 주식
34,226,000
배당수익률
-
주가수익률
26.38
주당순이익(EPS)
5.24
매출
3.4B
순이익
179.34M

Sartorius Ag 정보

섹터
Special Industry Machy, Nec
산업
Special Industry Machinery
웹사이트
www.sartorius.com
본부
Goettingen, Deu
설립됨
1870
Sartorius Ag is listed in the Special Industry Machy sector of the 런던증권거래소 with ticker 0NIQ. The last closing price for Sartorius was 138.25 €. Over the last year, Sartorius shares have traded in a share price range of 138.25 € to 138.25 €.

Sartorius currently has 34,226,000 shares in issue. The market capitalisation of Sartorius is 4.73 € billion. Sartorius has a price to earnings ratio (PE ratio) of 26.38.

0NIQ 최신 뉴스

추가 뉴스

Sartorius with clear double-digit growth in fiscal 2022

Sartorius with clear double-digit growth in fiscal 2022 PR Newswire GÖTTINGEN, Germany, Jan. 26, 2023 Preliminary figures for 2022: Sales revenue up 15.0 percent in constant currencies...

26 1월 2023
PR Newswire (US)

Sartorius successfully places Schuldschein loans with a volume of 650 million euros

Sartorius successfully places Schuldschein loans with a volume of 650 million euros PR Newswire GÖTTINGEN, Germany, Nov. 11, 2022 Volume increased from 300 million euros to 650 million...

11 11월 2022
PR Newswire (US)

Sartorius with continued growth in a challenging environment

Sartorius with continued growth in a challenging environment PR Newswire GÖTTINGEN, Germany, Oct. 19, 2022 Figures for the first nine months of 2022: Sales revenue up 16.6 percent in constant...

19 10월 2022
PR Newswire (US)

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions PR Newswire GÖTTINGEN, Germany, Aug. 8, 2022 - UK-based Albumedix Ltd. is a leader in the...

09 8월 2022
PR Newswire (US)

Sartorius remains on growth track

Sartorius remains on growth track PR Newswire GÖTTINGEN, Germany, July 21, 2022 Figures for the first half of 2022: Sales revenue up 20.9 percent in constant currencies, underlying EBITDA up 25.6...

21 7월 2022
PR Newswire (US)

Sartorius continues global capacity expansion with opening of extended plant in Tunisia

Sartorius continues global capacity expansion with opening of extended plant in Tunisia PR Newswire M'HAMDIA, Tunisia, May 19, 2022 Opening of a new 10,000 square-meter building in M'HamdiaNew...

19 5월 2022
PR Newswire (US)

Resolutions of the Annual General Shareholders' Meeting of Sartorius AG

Resolutions of the Annual General Shareholders' Meeting of Sartorius AG PR Newswire GÖTTINGEN, Germany, March 25, 2022 GÖTTINGEN, Germany, March 25, 2022 /PRNewswire/ -- At today's virtual Annual...

25 3월 2022
PR Newswire (US)

Sartorius Annual General Shareholders' Meeting: Focus on innovation, growth and sustainability

Sartorius Annual General Shareholders' Meeting: Focus on innovation, growth and sustainability PR Newswire GÖTTINGEN, Germany, March 25, 2022 GÖTTINGEN, Germany, March 25, 2022 /PRNewswire/ -- On...

25 3월 2022
PR Newswire (US)

Sartorius presents annual report for 2021

Sartorius presents annual report for 2021 PR Newswire GÖTTINGEN, Germany, Feb. 17, 2022 GÖTTINGEN, Germany, Feb. 17, 2022 /PRNewswire/ -- The life science group Sartorius today has presented its...

17 2월 2022
PR Newswire (US)

The Supervisory Board of Sartorius AG proposes dividend of 1.26 euros per preference share

The Supervisory Board of Sartorius AG proposes dividend of 1.26 euros per preference share - Dividend proposal of 1.26 euros per preference share and 1.25 euros per ordinary share - Frank...

10 2월 2022
PR Newswire (US)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
100138.25138.25138.25421138.25DE
400138.25138.25138.25216138.25DE
1200138.25138.25138.25249138.25DE
2600138.25138.25138.25350138.25DE
5200138.25138.25138.25562138.25DE
15600138.25138.25138.25720138.25DE
26000138.25138.25138.25504138.25DE

0NIQ - Frequently Asked Questions (FAQ)

What is the current Sartorius share price?
The current share price of Sartorius is 138.25 €
How many Sartorius shares are in issue?
Sartorius has 34,226,000 shares in issue
What is the market cap of Sartorius?
The market capitalisation of Sartorius is EUR 4.73B
What is the 1 year trading range for Sartorius share price?
Sartorius has traded in the range of 138.25 € to 138.25 € during the past year
What is the PE ratio of Sartorius?
The price to earnings ratio of Sartorius is 26.38
What is the cash to sales ratio of Sartorius?
The cash to sales ratio of Sartorius is 1.39
What is the reporting currency for Sartorius?
Sartorius reports financial results in EUR
What is the latest annual turnover for Sartorius?
The latest annual turnover of Sartorius is EUR 3.4B
What is the latest annual profit for Sartorius?
The latest annual profit of Sartorius is EUR 179.34M
What is the registered address of Sartorius?
The registered address for Sartorius is WEENDER LANDSTRA��E 94-108, GOETTINGEN, 37075
What is the Sartorius website address?
The website address for Sartorius is www.sartorius.com
Which industry sector does Sartorius operate in?
Sartorius operates in the SPECIAL INDUSTRY MACHINERY sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M

토론

전체 피드 보기
lovethatgreen lovethatgreen 4 분 전
I don't think there is a group anymore it's just him and he's broke
SINC
Shawonsarker84 Shawonsarker84 4 분 전
Still number 4 volume leader 275M traded so far. GL
HMBL
ron_66271 ron_66271 4 분 전
Poor Answer. I Win.

Project West!

CRA.

Why BO?
He did his function as JD required.

JD isn’t going to be Treasure Secretary.

JD is highly conflicted and responsible for the Derivative Market Meltdown of 2008.
COOP
imho imho 6 분 전
"Investor
Hard to argue with those highlighted facts!"

Let me ask you a question. What does the term "both" refer to in Investors highlighted portion referenced below?

"The trial met both its co-primary and key secondary endpoints, showing statistically signific
AVXL
XMaster2023 XMaster2023 6 분 전
You mean, feel free to refute your conjecture. No thanks. I have made a living assessing people and their motives. I believe in LP. You on the other hand. It’s apparent you are a paid basher. Thanks for deleting my post. I keep records, and the lawyers will enjoy your tactics.
NWBO
weedtrader420 weedtrader420 10 분 전
BITCOIN XRP AIMAW Aqualung💦Cross eyed Mary $120,000 TARGET ✊😮‍💨☝️
BTCUSD
Saving Grace Saving Grace 12 분 전
Yes, when NDA's are removed, it's boom time. Everyone at the plant is excited and ready.

https://businessjournaldaily.com/wp-content/uploads/2024/10/Foxconn-Model-C-EV.jpg

https://i.vimeocdn.com/video/1780032285-1eadf9821975b71cc554aa3a7d443a4b59265d9b3a16081b2573d7c443
NRDE
ThoroughBread ThoroughBread 14 분 전
SFIO .0028 sleeper.
SFIO
glens0 glens0 15 분 전
CTOR last Aug. 6th the price was $49.00 now $1.32
CTOR
ThoroughBread ThoroughBread 17 분 전
SING @ .006 bounce-pop off this level. Daily volume increasing.
boi568 boi568 17 분 전
Yes, it's also true that guidelines allow for more discretion than rules. To a point.

If the governing science that applies to two applicants is the same, the FDA decisional criteria should be the same. In this case, if the AD stages in the trials are the same, the endpoints should be
AVXL
Hardazoak Hardazoak 18 분 전
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 18 분 전
KPIFF
wadegarret wadegarret 19 분 전
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 19 분 전
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 20 분 전
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 21 분 전
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 21 분 전
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 22 분 전
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 22 분 전
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 24 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 24 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 25 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 26 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL

최근 히스토리

LSE
0NIQ
Sartorius
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유